Tarsus Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TARS and other ETFs, options, and stocks.About TARS
Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of therapeutic candidates. Its product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of blepharitis caused by the infestation of Demodex mites, which is referred to as Demodex blepharitis.
CEOBobak Azamian
CEOBobak Azamian
Employees323
Employees323
HeadquartersIrvine, California
HeadquartersIrvine, California
Founded2017
Founded2017
Employees323
Employees323
TARS Key Statistics
Market cap3.47B
Market cap3.47B
Price-Earnings ratio-40.40
Price-Earnings ratio-40.40
Dividend yield—
Dividend yield—
Average volume441.59K
Average volume441.59K
High today$83.34
High today$83.34
Low today$80.51
Low today$80.51
Open price$82.33
Open price$82.33
Volume428.40K
Volume428.40K
52 Week high$85.25
52 Week high$85.25
52 Week low$38.51
52 Week low$38.51
Stock Snapshot
Tarsus Pharmaceuticals(TARS) stock is priced at $81.35, giving the company a market capitalization of 3.47B. It carries a P/E multiple of -40.40.
On 2025-12-13, Tarsus Pharmaceuticals(TARS) stock moved within a range of $80.51 to $83.34. With shares now at $81.35, the stock is trading +1.0% above its intraday low and -2.4% below the session's peak.
Trading volume for Tarsus Pharmaceuticals(TARS) stock has reached 428.4K, versus its average volume of 441.59K.
The stock's 52-week range extends from a low of $38.51 to a high of $85.25.
The stock's 52-week range extends from a low of $38.51 to a high of $85.25.
Analyst ratings
90%
of 10 ratingsBuy
90%
Hold
10%
Sell
0%
People also own
Based on the portfolios of people who own TARS. This list is generated using Robinhood data, and it’s not a recommendation.